Canadian Biotech Duo Hits Psilocybin Extraction Milestone For API Development At Scale
Red Light Holland and PharmAla achieve psilocybin extraction milestone, advancing API development for scalable medical products. Read now!
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans’ Trips And More
Welcome to Benzinga’s psychedelic headlines roundup. This is our pick of must-read news items from the first two…
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
Welcome to Benzinga’s psychedelic headlines roundup. This is our pick of must-read news items from the last two…
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta’s Influence
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression Partners Beckley Psytech and atai Life Sciences (NASDAQ:ATAI) have…
PharmAla’s Novel MDMA Mixture Awarded US Patent, Enabling IP Protection And Further Development
The U.S. Patent and Trademark Office (USPTO) has granted PharmAla Biotech Holdings (OTC:MDXXF) a national patent covering the…
Two Top Biotechs Forge MDMA Supply Deals For An Expanding Research Field
Two separate deals hit the wires on Tuesday. One is PharmAla Biotech’s (OTC:OPTHF) with Tel Aviv University for…
Psychedelics Headlines: Trauma-Informed Care, Valentine’s Day & MDMA, Academics On Drugs And More
Welcome to Benzinga’s psychedelics headlines roundup. This is our pick of must-read news items concerning the last few…
Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, ‘Synthetic Surprise,’ UK’s Harm Reduction Hub And More
Discover the latest research on psychedelics, from anti-inflammatory effects to end-of-life therapy. New journal issue and online course available.